Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Morace, F.
121  Ergebnisse:
Personensuche X
?
1

P.12.13: Advantages of Transnasal Esophagogastroduodenoscop..:

Caravelli, G. ; Di Pierro, M. ; Morace, F...
Digestive and Liver Disease.  49 (2017)  - p. e217 , 2017
Link: https://doi.org/10.1016/..
 
?
2

P.01.12 VACCINATION STATUS IN INFLAMMATORY BOWEL DISEASE PA..:

Morace, F. ; Amalfi, G. ; Caravelli, G....
Digestive and Liver Disease.  45 (2013)  - p. S93 , 2013
Link: https://doi.org/10.1016/..
 
?
3

P.16.8 INFLIXIMAB'S ACUTE INFUSION REACTION IN INFLAMMATORY..:

Morace, F. ; Amalfi, G. ; Caravelli, G....
Digestive and Liver Disease.  44 (2012)  - p. S192 , 2012
Link: https://doi.org/10.1016/..
 
?
4

P.1.75: REVALUATION OF RISK FACTORS FOR INFLAMMATORY BOWEL ..:

Castiglione, F. ; Meucci, C. ; Morace, F....
Digestive and Liver Disease.  43 (2011)  - p. S173 , 2011
Link: https://doi.org/10.1016/..
 
?
5

P.1.272: CLINICAL RELAPSES AND MUCOSAL HEALING IN PATIENTS ..:

Morace, F. ; Amalfi, G. ; Caravelli, G....
Digestive and Liver Disease.  43 (2011)  - p. S238-S239 , 2011
Link: https://doi.org/10.1016/..
 
?
6

P.94 USE OF INFLIXIMAB IN HBV PATIENTS:

Morace, F. ; Di Pierro, M. ; Amalfi, G....
Digestive and Liver Disease.  42 (2010)  - p. S136 , 2010
Link: https://doi.org/10.1016/..
 
?
7

FECAL CALPROTECTIN: A SPECIFIC MARKER OF INTESTINAL RELAPSE..:

Morace, F. ; Amalfi, G. ; Caravelli, G....
Digestive and Liver Disease.  41 (2009)  - p. S32 , 2009
Link: https://doi.org/10.1016/..
 
?
8

OC3.03.8 IS FECAL CALPROTECTIN A MARKER FOR MUCOSAL HEALING..:

D'Angelo, V. ; Morace, F. ; Amalfi, G....
Digestive and Liver Disease.  40 (2008)  - p. S44-S45 , 2008
Link: https://doi.org/10.1016/..
 
?
9

Iron overload in chronic liver diseases and clinical useful..:

Farinato, C. ; Di Pierro, M. ; Amalfi, G....
Digestive and Liver Disease.  38 (2006)  - p. S185 , 2006
Link: https://doi.org/10.1016/..
 
?
10

Fecal calprotectin and contrast enhanced transabdominal ult..:

Morace, F. ; D'Angelo, V. ; Amalfi, G....
Digestive and Liver Disease.  38 (2006)  - p. S13-S14 , 2006
Link: https://doi.org/10.1016/..
 
?
11

A case report: Fibrolamellar carcinoma:

Amalfi, G. ; Di Pierro, M. ; Farinato, C....
Digestive and Liver Disease.  38 (2006)  - p. S198 , 2006
Link: https://doi.org/10.1016/..
 
?
12

Contrast enhanced transabdominal ultrasonography in inflixi..:

D'Angelo, V. ; Pierro, M. Di ; Morace, F....
Digestive and Liver Disease.  38 (2006)  - p. S41 , 2006
Link: https://doi.org/10.1016/..
 
?
13

63 P Long term infliximab treatment of a unconventional eso..:

Morace, F. ; Marone, A. ; Pumpo, R...
Digestive and Liver Disease.  34 (2002)  - p. A92 , 2002
Link: https://doi.org/10.1016/..
 
?
14

Un unconventional case of esophageal Crohn's disease respon..:

Marone, G.P. ; Morace, F. ; Marone, A...
Digestive and Liver Disease.  33 (2001)  - p. A70 , 2001
Link: https://doi.org/10.1016/..
 
?
15

Intestinal permeability to cellobiose and mannitol in Crohn..:

Secondulfo, M. ; deMagistris, L. ; Riegler, G....
Gastroenterology.  114 (1998)  - p. A1082 , 1998
Link: https://doi.org/10.1016/..
 
1-15